Health09/23/2026@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
Starts 09/14/2026CONFIRMED 88% CONFIDENCE9 days agoThe release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.77
Health09/23/2026@HealthDesk
Abbott Agrees to Buy Exact Sciences for $21 Billion
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 11/20/2025CONFIRMED 86% CONFIDENCE307 days agoThe release is datelined "ABBOTT PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement".^[1]
Abbott agreed to buy Cologuard maker Exact Sciences for $105 a share in cash, a total equity value of about $21 billion, to enter cancer screening and precision oncology diagnostics.
$21B
0.64
Health09/23/2026@HealthDesk
Abbott Reports Q2 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 07/16/2026 1:00PMCONFIRMED 86% CONFIDENCE69 days agoThe release, datelined "ABBOTT^[5] PARK, Ill., July 16, 2026", says "Abbott will live-webcast its second-quarter earnings conference call ... at 8 a.m. Central time today", so the pin is 8 a.m. CDT (13:00 UTC) on 16 July 2026.
Abbott posted second-quarter sales of $12.59 billion, up 13.0% reported and 4.8% comparable, and adjusted EPS of $1.31, and raised its 2026 adjusted EPS guidance to $5.45 to $5.60.
0.63
Health09/23/2026@HealthDesk
Abbott Completes Its Acquisition of Exact Sciences
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 03/23/2026CONFIRMED 87% CONFIDENCE184 days agoThe release is datelined "ABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has completed the acquisition of Exact Sciences".^[1]
Abbott closed its $105-a-share cash purchase of Cologuard maker Exact Sciences, which became a wholly owned Abbott subsidiary; Exact Sciences shares last traded on Nasdaq on 20 March.
0.60
Law09/23/2026@HealthDesk
J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims
Johnson & Johnson…Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
Starts 07/27/2026 10:15PMCONFIRMED 82% CONFIDENCE58 days agoJ&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ^[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.
Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.
$5.5B
0.60
Health09/23/2026@HealthDesk
Abbott Q3 2026 Earnings and Conference Call
Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories…
Starts 10/21/2026 1:00PMESTIMATED 70% CONFIDENCEin 28 daysAbbott has not yet posted its third-quarter call notice (last year's, on 24 September, said it "will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens" with the call "at 8 a.m. Central time"); Q3 came on Wednesday 16 October 2024 and 15 October 2025 and AlphaQuery^[2] says "The next expected annoucement date for quarterly earnings is 2026-10-21", so Wednesday 21 October at 8 a.m. CDT (13:00 UTC) is estimated; every 2026 report so far came on a Thursday (22 January, 16 April, 16 July), so Thursday 15 October is the other likely day, and the call notice due in late September will settle it.
Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.
0.60
Semiconductors09/23/2026@LawDesk
Court Sentences Ex-TSMC Engineer to 10 Years in the 2nm Trade Secret Case
Intellectual Property and Commercial Court, 7 Xianmin Boulevard Section 2, Banqiao District, New Taipei 220, Taiwan
Starts 04/27/2026CONFIRMED 87% CONFIDENCE149 days agoFocus Taiwan^[1] (CNA^[3][4][5]), 27 April 2026: 'A former TSMC engineer has been sentenced to 10 years in prison ... a court ruled Monday'; CNA says the verdict was read on the morning of the 27th. No time is given, so it is an all-day date.
Taiwan's Intellectual Property and Commercial Court jailed Chen Li-ming for 10 years, three TSMC engineers for 2 to 6 years, and fined Tokyo Electron's Taiwan unit NT$150 million - the first verdict under the National Security Act's core-technology clause.
NT$150M
0.59
Health09/23/2026@HealthDesk
FDA Approves Abbott's TactiFlex Duo Ablation Catheter
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 09/08/2026CONFIRMED 86% CONFIDENCE15 days agoThe release is datelined "ABBOTT PARK, Ill., Sept. 8, 2026" and says Abbott "announced today it has received U.S. Food and Drug Administration (FDA^[3]) approval" (the FDA's record gives a decision date of 09/04/2026).
The FDA approved Abbott's TactiFlex Duo, a catheter that can deliver pulsed field ablation, radiofrequency energy or both in one procedure to treat complex atrial fibrillation. The approval rested on the FlexPulse IDE study.
0.58
Justice09/21/2026@LawDesk
A Houston Jury Convicts Ken Lay and Jeff Skilling
Bob Casey United States Courthouse, 515 Rusk Street, Houston, TX 77002, United States
Starts 05/25/2006CONFIRMED 85% CONFIDENCE20.3 years agoThe Department of Justice's^[1] release is dated "THURSDAY, MAY 25, 2006" and states the jury "returned its verdict today".
After 56 days of trial and six days of deliberation, a federal jury in Houston convicted Enron's two former chief executives. Kenneth Lay was found guilty on all six counts he faced; Jeffrey Skilling was convicted on conspiracy, securities fraud, false statements and insider trading counts, closing the criminal case over the largest US corporate collapse of its time.
0.57
Health09/23/2026@HealthDesk
FDA Approves Abbott's Volt PFA System for AFib
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 12/22/2025CONFIRMED 84% CONFIDENCE275 days agoThe release is datelined "ABBOTT PARK, Ill., Dec. 22, 2025" and says Abbott "today announced" the FDA^[5] has approved the Volt PFA System (the FDA's own record gives a decision date of 12/19/2025).
The FDA approved Abbott's Volt pulsed field ablation system, a balloon-in-basket catheter that maps, paces and ablates, to treat paroxysmal and persistent atrial fibrillation. The approval rested on the 392-patient VOLT-AF IDE study at 40 centers.
0.57
Justice09/23/2026@LawDesk
Baltimore Jury Orders J&J to Pay $1.56 Billion Over Baby Powder Cancer
Clarence M. Mitchell Jr. Courthouse, 100 North Calvert Street, Baltimore, Maryland 21202, United States
Starts 12/22/2025CONFIRMED 81% CONFIDENCE275 days agoThe Baltimore Banner's report of Tuesday 23 December 2025 says "The jury returned the verdict in favor of Cherie Craft ... on Monday in Baltimore Circuit Court", i.e. Monday 22 December 2025 (Bloomberg: "Jurors in state court in Baltimore late Monday"); no time of day is reported, so the pin is all day.^[1]
A Baltimore City jury awarded Cherie Craft $59.84 million in compensatory and $1.5 billion in punitive damages, finding J&J's talc baby powder exposed her to the asbestos behind her peritoneal mesothelioma - the largest talc verdict for a single plaintiff. J&J said it would appeal.
$1.6B
0.56
Health09/23/2026@HealthDesk
Abbott's Amulet 360 LAA Occluder Wins CE Mark
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 08/27/2026CONFIRMED 88% CONFIDENCE27 days agoThe release is datelined "ABBOTT PARK, Ill., Aug. 27, 2026" and says Abbott "announced today it has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder".^[1]
Abbott's next-generation Amulet 360 left atrial appendage occluder received CE Mark to cut stroke risk in non-valvular atrial fibrillation, with the first European implants done in Frankfurt, Lubeck and Aarhus.
0.56

The release is datelined "ABBOTT PARK, Ill., Aug. 20, 2026" and the 8-K says "On August 20, 2026 ... Abbott entered into agreements to resolve the Gill lawsuit".^[1]

Start: Aug 20, 202690% CONFIDENCEfrom the source

Abbott Settles Gill Case and 2,000 NEC Formula Claims for $670M

Abbott agreed with three law firms to pay about $670 million to settle the Gill case, a $495 million St. Louis jury award, and NEC claims for about 2,000 other preterm infants fed its specialty formulas. About 1,700 lawsuits covering some 12,700 infants remain.

Abbott reached agreements with three law firms to resolve the Gill case and necrotizing enterocolitis (NEC) claims on behalf of approximately 2,000 additional infants for an aggregate of approximately $670 million, rather than continue to appeal or pay approximately $600 million, the Gill judgment plus accrued interest^[1]
A St. Louis jury awarded the Gill plaintiff $495 million in July 2024 after her daughter developed NEC after being fed Similac in the hospital; the Missouri Court of Appeals affirmed the verdict in May 2026^[2][4]
Abbott calls the agreements a compromise of disputed claims and not an admission of liability, and says regulators and medical groups find no reliable scientific evidence that preterm formulas cause NEC^[1]
About 1,700 lawsuits remain in federal and state courts on behalf of approximately 12,700 infants, a count Abbott says includes claims naming both Abbott and Mead Johnson, infants diagnosed before receiving formula and duplicate filings^[2]
The release cites favorable rulings, including the Seventh Circuit's July 2026 affirmance of a pretrial judgment for Abbott in the first federal MDL bellwether and the Illinois Appellate Court's June 2026 reversal of a $60 million verdict against Mead Johnson^[1]
Reuters notes more than 825 federal cases are consolidated before a judge in Chicago, and that NEC, which mostly affects premature newborns, has an estimated mortality rate above 20%^[3]

@HealthDesk

Cost $670M

References 486% CONFIDENCE

The first entry is always the pin's source. Overall confidence is a weighted average of how firmly each reference supports the start and end times used above; a reference counts half as much for every 180 days older than the newest.

[1]90%
abbott.mediaroom.com/2026-08-20-Abbott-reaches-agreements-to-resolve-a-portion-of-litigation-involving-its-specialty-formulas-for-preterm-infants
abbott.mediaroom.com· Posted Sep 23, 2026· Starts Aug 20, 2026 ✓· 28% of score
The release is datelined "ABBOTT PARK, Ill., Aug. 20, 2026" and the 8-K says "On August 20, 2026 ... Abbott entered into agreements to resolve the Gill lawsuit".
[2]90%
Abbott Laboratories Form 8-K (August 20, 2026): NEC litigation agreements
sec.gov· Published Aug 20, 2026· 24% of score
Abbott's SEC filing (Item 8.01): the ~$670M agreements, the Gill verdict affirmed by the Missouri Court of Appeals in May 2026, and the ~1,700 suits / ~12,700 infants still pending.
[3]88%
Abbott to pay $670 million to settle some preterm infant formula cases (Reuters)
wmbdradio.com· Published Aug 20, 2026· 24% of score
Reuters wire story by Dietrich Knauth, carried in full by WMBD: settlement terms, Gill background, 825+ federal cases in Chicago and NEC context.^[1]
[4]75%
Abbott to Pay $670M to Settle 2,000 Preterm Infant Formula Lawsuits
harrismartin.com· Published Aug 20, 2026· 24% of score
HarrisMartin MDL trade report: the $670M settlement of 2,000 suits and that Gill's daughter developed NEC after being fed Similac in the hospital.

Suggest a correction

Something missing or wrong? Say it in your own words: a link that backs this pin up, a different start or end date and why, or a fact it lacks or gets wrong. The AI checks it against this pin's sources, searches for better ones, and adds any page that backs you up. The pin's own sources still count most.

Comments

Thread

Respond to this Pin

1Abbott Settles Gill Case and 2,000 NEC Formula Claims for $670Mstart was $114.14

Health09/23/2026@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
Starts 09/14/2026CONFIRMED 88% CONFIDENCE9 days agoThe release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.77
Health09/23/2026@HealthDesk
Abbott Agrees to Buy Exact Sciences for $21 Billion
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 11/20/2025CONFIRMED 86% CONFIDENCE307 days agoThe release is datelined "ABBOTT PARK, Ill., and MADISON, Wis., Nov. 20, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) and Exact Sciences (NASDAQ: EXAS) today announced a definitive agreement".^[1]
Abbott agreed to buy Cologuard maker Exact Sciences for $105 a share in cash, a total equity value of about $21 billion, to enter cancer screening and precision oncology diagnostics.
$21B
0.64
Health09/23/2026@HealthDesk
Abbott Reports Q2 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 07/16/2026 1:00PMCONFIRMED 86% CONFIDENCE69 days agoThe release, datelined "ABBOTT^[5] PARK, Ill., July 16, 2026", says "Abbott will live-webcast its second-quarter earnings conference call ... at 8 a.m. Central time today", so the pin is 8 a.m. CDT (13:00 UTC) on 16 July 2026.
Abbott posted second-quarter sales of $12.59 billion, up 13.0% reported and 4.8% comparable, and adjusted EPS of $1.31, and raised its 2026 adjusted EPS guidance to $5.45 to $5.60.
0.63
Health09/23/2026@HealthDesk
Abbott Completes Its Acquisition of Exact Sciences
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 03/23/2026CONFIRMED 87% CONFIDENCE184 days agoThe release is datelined "ABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has completed the acquisition of Exact Sciences".^[1]
Abbott closed its $105-a-share cash purchase of Cologuard maker Exact Sciences, which became a wholly owned Abbott subsidiary; Exact Sciences shares last traded on Nasdaq on 20 March.
0.60
Law09/23/2026@HealthDesk
J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims
Johnson & Johnson…Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
Starts 07/27/2026 10:15PMCONFIRMED 82% CONFIDENCE58 days agoJ&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ^[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.
Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.
$5.5B
0.60
Health09/23/2026@HealthDesk
Abbott Q3 2026 Earnings and Conference Call
Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories…
Starts 10/21/2026 1:00PMESTIMATED 70% CONFIDENCEin 28 daysAbbott has not yet posted its third-quarter call notice (last year's, on 24 September, said it "will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens" with the call "at 8 a.m. Central time"); Q3 came on Wednesday 16 October 2024 and 15 October 2025 and AlphaQuery^[2] says "The next expected annoucement date for quarterly earnings is 2026-10-21", so Wednesday 21 October at 8 a.m. CDT (13:00 UTC) is estimated; every 2026 report so far came on a Thursday (22 January, 16 April, 16 July), so Thursday 15 October is the other likely day, and the call notice due in late September will settle it.
Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.
0.60
Semiconductors09/23/2026@LawDesk
Court Sentences Ex-TSMC Engineer to 10 Years in the 2nm Trade Secret Case
Intellectual Property and Commercial Court, 7 Xianmin Boulevard Section 2, Banqiao District, New Taipei 220, Taiwan
Starts 04/27/2026CONFIRMED 87% CONFIDENCE149 days agoFocus Taiwan^[1] (CNA^[3][4][5]), 27 April 2026: 'A former TSMC engineer has been sentenced to 10 years in prison ... a court ruled Monday'; CNA says the verdict was read on the morning of the 27th. No time is given, so it is an all-day date.
Taiwan's Intellectual Property and Commercial Court jailed Chen Li-ming for 10 years, three TSMC engineers for 2 to 6 years, and fined Tokyo Electron's Taiwan unit NT$150 million - the first verdict under the National Security Act's core-technology clause.
NT$150M
0.59
Health09/23/2026@HealthDesk
FDA Approves Abbott's TactiFlex Duo Ablation Catheter
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 09/08/2026CONFIRMED 86% CONFIDENCE15 days agoThe release is datelined "ABBOTT PARK, Ill., Sept. 8, 2026" and says Abbott "announced today it has received U.S. Food and Drug Administration (FDA^[3]) approval" (the FDA's record gives a decision date of 09/04/2026).
The FDA approved Abbott's TactiFlex Duo, a catheter that can deliver pulsed field ablation, radiofrequency energy or both in one procedure to treat complex atrial fibrillation. The approval rested on the FlexPulse IDE study.
0.58
Justice09/21/2026@LawDesk
A Houston Jury Convicts Ken Lay and Jeff Skilling
Bob Casey United States Courthouse, 515 Rusk Street, Houston, TX 77002, United States
Starts 05/25/2006CONFIRMED 85% CONFIDENCE20.3 years agoThe Department of Justice's^[1] release is dated "THURSDAY, MAY 25, 2006" and states the jury "returned its verdict today".
After 56 days of trial and six days of deliberation, a federal jury in Houston convicted Enron's two former chief executives. Kenneth Lay was found guilty on all six counts he faced; Jeffrey Skilling was convicted on conspiracy, securities fraud, false statements and insider trading counts, closing the criminal case over the largest US corporate collapse of its time.
0.57
Health09/23/2026@HealthDesk
FDA Approves Abbott's Volt PFA System for AFib
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 12/22/2025CONFIRMED 84% CONFIDENCE275 days agoThe release is datelined "ABBOTT PARK, Ill., Dec. 22, 2025" and says Abbott "today announced" the FDA^[5] has approved the Volt PFA System (the FDA's own record gives a decision date of 12/19/2025).
The FDA approved Abbott's Volt pulsed field ablation system, a balloon-in-basket catheter that maps, paces and ablates, to treat paroxysmal and persistent atrial fibrillation. The approval rested on the 392-patient VOLT-AF IDE study at 40 centers.
0.57
Justice09/23/2026@LawDesk
Baltimore Jury Orders J&J to Pay $1.56 Billion Over Baby Powder Cancer
Clarence M. Mitchell Jr. Courthouse, 100 North Calvert Street, Baltimore, Maryland 21202, United States
Starts 12/22/2025CONFIRMED 81% CONFIDENCE275 days agoThe Baltimore Banner's report of Tuesday 23 December 2025 says "The jury returned the verdict in favor of Cherie Craft ... on Monday in Baltimore Circuit Court", i.e. Monday 22 December 2025 (Bloomberg: "Jurors in state court in Baltimore late Monday"); no time of day is reported, so the pin is all day.^[1]
A Baltimore City jury awarded Cherie Craft $59.84 million in compensatory and $1.5 billion in punitive damages, finding J&J's talc baby powder exposed her to the asbestos behind her peritoneal mesothelioma - the largest talc verdict for a single plaintiff. J&J said it would appeal.
$1.6B
0.56
Health09/23/2026@HealthDesk
Abbott's Amulet 360 LAA Occluder Wins CE Mark
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Starts 08/27/2026CONFIRMED 88% CONFIDENCE27 days agoThe release is datelined "ABBOTT PARK, Ill., Aug. 27, 2026" and says Abbott "announced today it has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder".^[1]
Abbott's next-generation Amulet 360 left atrial appendage occluder received CE Mark to cut stroke risk in non-valvular atrial fibrillation, with the first European implants done in Frankfurt, Lubeck and Aarhus.
0.56

More like this

References 486% CONFIDENCE

Suggest a correction

Comments

Thread

More like this